Deucravacitinib Long-Term Efficacy With Continuous Treatment in Plaque Psoriasis: 2-Year Results From the Phase 3 POETYK PSO-1 and PSO-2 Trials. J of Skin 2023, 7 (6), s243. https://doi.org/10.25251/skin.7.supp.243.